Description

As a strategic leader with over 15 years of experience across commercial operations and program management, I thrive on driving transformative initiatives that enhance business performance and deliver sustainable growth in the Life Sciences sector.

Passionate about advancing the future of healthcare, I have a proven ability to navigate complex environments across geographies and therapeutic areas. From leading a significant AI-driven engagement program to managing a multi-billions neuroscience portfolio, my approach is rooted in innovation, collaboration, and results-driven execution.

I’m deeply motivated by creating positive change-whether through strategic decision-making or fostering growth within teams.

Languages

French
Native or bilingual
English
Native or bilingual
Italian
Conversational
Spanish
Conversational

Workplace preferences

Can work on-site

Genève (up to 50km)

Johnson & Johnson Innovative Medicine
Sr Director, Global Commercial Strategy Operations & Insights, Cardiopulmonary
November 2022 - Today (3 years and 7 months)
Switzerland
Develop Therapeutic Area (TA) strategy definition, aspiration and goals
Act as Chief of Staff for the TA Leadership Team: lead strategic agenda, coordinate scenario planning, orchestrate reviews vs key milestones
Maintain oversight on Disease Areas including functional integration between Commercial, R&D and New Business Development
Drive execution of TA re-organization post R&D portfolio prioritization
Coordinate key touchpoints between Global and Regions to inform Disease Area Strategy and support execution at affiliate level
Lead team of 5 to deliver Commercial Insights (forecasting, analytics, market research and competitive intelligence) to inform TA strategy
Provide forecast leading to valuation of internal pipeline and potential external acquisitions in line with TA priorities
Janssen, Pharmaceutical Company of Johnson & Johnson
EMEA Program Director, AI Customer Engagement
January 2020 - October 2022 (2 years and 9 months)
Switzerland
Led overall delivery of a +$30 M company strategic initiative providing data-driven recommendations to guide field interactions with HCPs
Ensured timely and at-scale delivery of the solution including change management: 6 brands deployed in 6 markets over 18 months
Ran governance model supporting swift & streamlined decision process with clear articulation of roles between region & operating companies
Led the core and extended project teams (>50 people)
Janssen, Pharmaceutical Company of Johnson & Johnson
EMEA Commercial Strategy Director, Neuroscience
January 2018 - January 2020 (2 years)
France
Drove EMEA integrated strategic brand plans of >$1 bn schizophrenia long-acting injectable portfolio (Xeplion®, Trevicta®, Consta®)
Delivered 15% YoY net trade sales growth 2 years in a row with sustained leadership vs competition through execution of brand plan
Delivered recommendation and plan to launch new product - Palmitate Paliperidone 6-monthly - across EMEA
Provided input to global compound development team to ensure successful registration, reimbursement and listing across EMEA
Drove execution of company program leading to marketing cost reduction by 30% and strengthening of alignment with affiliates
Led cross-functional regional team of 10 people and network of ~20 country commercial leads to drive tactical plan implementation